Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease.
Lüke F, Harrer DC, Menhart K, Wolff D, Holler E, Hellwig D, Herr W, Grube M, Vogelhuber M, Reichle A, Heudobler D.
Lüke F, et al. Among authors: harrer dc.
Front Pharmacol. 2021 Jun 18;12:599561. doi: 10.3389/fphar.2021.599561. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34220492
Free PMC article.